The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...

A new study by Celestino Sardu and colleagues, published in the International Journal of Molecular Sciences (2025), has found ...

The health agency supports the long-term use of the medications in combination with a healthy diet and exercise, and calls ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...

Over the last few years, GLP-1 medications, such as Ozempic and Wegovy, have gained immense popularity for treating type 2 diabetes and aiding weight loss. However, their effectiveness is not ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Eli Lilly’s new oral GLP-1 drug, orforglipron, is shaping up to be a major development in obesity treatment, showing nearly ...

Obesity is the excessive or abnormal accumulation of fat or adipose tissue in the body that impairs health via its ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...